Medicine

The Trump administration is retreating from a proposed executive order that would have given the White House greater control over National Institutes of Health grants, according to Semafor. The plan, which drew criticism from researchers and science advocates, is now reported to be effectively dead after widespread pushback from the scientific and medical community.

Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the Zaire strain responsible for the outbreak in the Democratic Republic of the Congo. The trial marks the first human testing of the candidate, which uses the same mRNA technology behind Moderna's COVID-19 vaccine. Coverage is highlighting the company's growing pipeline and the urgent need for new Ebola countermeasures in central Africa.

Stanford Medicine is reported to have revealed that the human brain functions as two distinct organs rather than a single one. The claim, picked up by the news outlet KRON 4, is drawing wide attention and debate about what the finding means for neuroscience and medicine.

As a heat wave grips much of the United States, doctors are warning that people taking GLP-1 medications, such as Ozempic and Wegovy, may face heightened health risks. These drugs can contribute to dehydration, which raises the danger of heat exhaustion and other heat-related illness. Health professionals are advising patients on GLP-1 therapies to drink plenty of fluids, limit strenuous outdoor activity, and watch for warning signs like dizziness and nausea during extreme temperatures.

Japan is considering stricter regulations on regenerative medicine as treatments in the field proliferate across the country. The move follows growing concern that clinics are offering unproven therapies under looser rules than those governing conventional drugs. Officials are debating how to balance patient access to innovative treatments with safety oversight, and medical groups are watching closely for what the revised framework could mean for practice.

Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.

Health reporting is warning about the risks of combining traditional Chinese medicine with Western prescription drugs. Herbal remedies can interact with pharmaceuticals, altering how drugs are absorbed or metabolised and potentially causing harmful side effects. Doctors advise patients to tell their physicians about any herbal treatments they use, as these often go unreported and can undermine treatment.

A federal bill has been proposed that would ban the corporate practice of medicine across the United States. If enacted, the legislation would restrict corporations from owning or employing physicians, a model that has expanded rapidly through private equity investment in healthcare. Law firms and healthcare industry observers are examining the proposal's potential effects on hospital ownership, staffing companies and patient care.

Feverish babies admitted to hospital are often assumed to have a serious bacterial infection and are treated with antibiotics as a precaution. A new test that gauges whether an infection is bacterial or viral could reduce unnecessary antibiotic use in infants, helping doctors avoid overprescription and supporting efforts against antimicrobial resistance.

Insilico Medicine has signed a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory, joining forces to apply large AI models to drug discovery. The Hong Kong-based biotech, known for using generative AI to design drug candidates, has not disclosed its partner or the exact terms, leaving observers speculating about which AI lab is behind the agreement.

Physicians are pushing back on hantavirus coverage, arguing news headlines have exaggerated the actual risk to the public. In other medical news, three people have been sentenced in a Moscow-based telemedicine fraud scheme worth roughly $2 billion, and new figures show one in ten surgeons leave the profession within eight years. The stories are circulating in a medical news roundup.

A thyroid medicine has been recalled and the recall has been classified under the FDA's most serious risk level, meaning the agency considers the product potentially capable of causing serious harm or death. The news is circulating among readers discussing medication safety and whether patients taking thyroid medication need to check their supply or consult a doctor.

Platform trials, which test multiple treatments simultaneously against a shared control group, are transforming how clinical evidence is generated, especially in emergencies like pandemics. Regulators have been slower to update their frameworks to evaluate evidence from these adaptive, multi-arm designs. The debate centers on whether existing approval standards can accommodate faster, more flexible trial methods without compromising patient safety or scientific rigor.

New reporting highlights that people living with type 2 diabetes face a growing risk of heart and kidney problems the longer they have the disease. The findings underscore why doctors stress early, sustained management of blood sugar, blood pressure and kidney function in diabetic patients.

A New York Times opinion piece asks why clinical trials for cancer drugs take so long, examining delays in the process of testing new treatments on patients. The article prompts discussion about whether trial design, regulatory requirements, or patient recruitment are the main bottlenecks in getting promising cancer therapies to people faster.

Ellis Medicine will host a community forum in Schenectady, New York, focused on the future of healthcare in the area. The event gives residents a chance to hear from hospital leadership and raise concerns about local medical services. Local news outlet NEWS10 ABC reported the announcement, drawing attention in the region.

Top-ranked Texas, No. 7 Ohio State and No. 11 Texas Tech all kept their perfect records intact in the latest round of college football results, while No. 16 Louisville suffered its first loss of the season. The results reshape the picture near the top of the rankings, with several unbeaten contenders still standing and Louisville now slipping from the unbeaten ranks.

No. 2 Georgia beat Oklahoma 41-13 in a lopsided college football game defined by Oklahoma's turnovers. Linebacker Cole returned a fumble 85 yards for a touchdown, one of the game's highlight plays. Georgia's dominant defense forced repeated mistakes, allowing the Bulldogs to pull away comfortably and reinforce their position near the top of the national rankings.

Southern Cross University is pursuing a strategy in India focused on building a scientific evidence base for traditional medicine. The initiative, reported by BioSpectrum Asia, signals growing collaboration between Australian researchers and India's traditional medicine sector, where validating herbal and ancient practices through rigorous research is an increasing priority for regulators, industry and academia.

The pairings for Sunday's singles matches at the Presidents Cup at Medinah have been released, setting up the final-day matchups between the United States and the International team. Golf fans are following the announcement closely, as the singles lineup can decide which side lifts the trophy.

A life-size replica of the Yuan dynasty Buddha of Medicine mural has gone on display at the National Arts and Crafts Museum in China. The exhibition brings one of the era's celebrated religious artworks to a wider public audience through a faithful full-scale reproduction, drawing attention to Yuan dynasty Buddhist art and the country's cultural heritage preservation efforts.

Jadan Baugh and No. 21 Florida overpowered fourth-ranked Ole Miss 52-28 in a college football upset. The Gators' dominant win over a top-five opponent is drawing wide attention, with fans and analysts highlighting Baugh's performance and the damage the result does to Ole Miss's ranking and playoff hopes.

The University of Nebraska Board of Regents has approved the university's representatives to the Nebraska Medicine board, formalising institutional oversight and participation in the health system's governance. The move aligns the university's leadership with Nebraska Medicine's operations. Broader public reaction has so far been limited, with coverage largely confined to regional news outlets reporting the board's routine approval.

The Second Ibero-American Symposium on Ethnoveterinary Medicine is drawing attention, with the Food and Agriculture Organization among those highlighting the event. The gathering brings together researchers and practitioners from across Ibero-America to discuss traditional and plant-based approaches to animal health, and how such knowledge can complement conventional veterinary practice.

Authorities in Kabul have carried out inspections of 75 medicine importers, according to Pajhwok Afghan News. The checks target companies bringing pharmaceutical products into Afghanistan, a sector long plagued by concerns over counterfeit and substandard drugs. The report has drawn attention regionally as Afghans follow efforts to improve oversight of the medicine supply chain.

Wake Forest beat 16th-ranked Louisville 30-27 in an away game, pulling off one of the notable upsets of the college football weekend. The Demon Deacons took down the ranked Cardinals on their home field, a result that could shake up the Atlantic Coast Conference race and the national rankings.

The University of Nebraska Board of Regents has approved the university's representatives to the Nebraska Medicine board, formalising the institution's seats in the governance of the health system. The approval strengthens the formal ties between the university and Nebraska Medicine, which partners closely with the university's medical centre in Omaha.

Bank of America Corp DE has disclosed a new position worth $9.88 million in Disc Medicine, Inc., the biotech company traded under the ticker IRON. The filing reveals the bank took a fresh stake in the clinical-stage firm, whose stock is often followed by institutional investors in the biotechnology sector.

The University of Nebraska Board of Regents has appointed four new members to the board of Nebraska Medicine, the state's largest health system. The appointments fill seats overseeing the hospital network affiliated with the University of Nebraska Medical Center in Omaha. No further details about the appointees or their terms were immediately available.